FDA Adverse Event Malfunction Summary report: N

CREATINE KINASE

MDR report key: 2171722 · Received July 22, 2011

Report

Report Number
1823260-2011-03898
Event Type
Malfunction
Date Received
July 22, 2011
Date of Event
June 28, 2011
Report Date
November 22, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JHS
PMA / PMN Number
K951595
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

FURTHER INVESTIGATION OF THE EVENT COULD NOT CLEARLY IDENTIFY A SPECIFIC ROOT CAUSE AS THE CUSTOMER REFUSED TO PROVIDE FURTHER DATA FOR THE ADDITIONAL EVALUATION. THE PROBLEM WAS SOLVED BY THE APPROPRIATE TROUBLESHOOTING PROCESS WHERE IT WAS FOUND THERE WAS A DILUTION OF THE REACTION BY A LEAKING R2 NOZZLE, AV2 VALVE BLOCK AND R2 NOZZLE. THESE PARTS WERE REPLACED DURING THE SERVICE VISIT. AS FAR AS IT WAS KNOWN, NO PATIENTS WERE ADVERSELY AFFECTED.

Description of Event or Problem · 1

THE CUSTOMER RECEIVED QUESTIONABLE RESULTS FOR MULTIPLE ASSAYS FOR APPROXIMATELY 15 PATIENTS WHEN TESTED ON A COBAS 6000 C501 MODULE, SERIAL NUMBER (B)(4). THE ASSAYS INCLUDED ALBUMIN (GENERATION 2), CREATININE KINASE, CREATININE (JAFFE GENERATION 2), ALKALINE PHOSPHATASE, HDL-CHOLESTEROL AND MAGNESIUM. THE INITIAL RESULTS WERE REPORTED OUTSIDE THE LABORATORY AND THE CUSTOMER SENT APPROXIMATELY 39 CORRECTED REPORTS. THE CUSTOMER RECEIVED "QUITE A FEW" CREATININE KINASE RESULTS OF <7U/L THAT WHEN REPEATED ON ANOTHER COBAS 6000 C501 ANALYZER RECOVERED "IN THE 100S U/L RANGE". NO ADVERSE EVENTS HAVE BEEN ALLEGED REGARDING THE DISCREPANCIES. THE FIELD SERVICE REPRESENTATIVE DETERMINED A DEFECTIVE VALVE ON THE VALVE BANK AV2 WAS THE CAUSE AND HE REPLACED THE VALVE BANK AV2. THE FIELD SERVICE REPRESENTATIVE TESTED THE REPLACEMENT VALVE AND VERIFIED THE INSTRUMENT WAS OPERATING WITHIN SPECIFICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CREATINE KINASE DIFFERENTIAL RATE KINETIC METHOD, CPK OR ISOENZYMES JHS ROCHE DIAGNOSTICS NA ASKU

Patients

Seq Age Sex Outcome Treatment
1